Introduction
The Gram-negative bacterium Thermus thermophilus, which was isolated from a hot spring in Japan (Henne et al. 2004; Oshima and Imahori 1974) , is an extremely thermophilic model organism, which can grow in temperatures up to 85 °C. T. thermophilus belongs to the phylum Deinococcus-Thermus, a small group of bacteria that are highly resistant to environmental hazards (Griffiths and Gupta 2007) . The genus Thermus is closely related to Archaea and the genus Mycobacterium in the phylogenetic tree (Omelchenko et al. 2005) .
Toxin-antitoxin (TA) loci are widely distributed in chromosomes and plasmids of Bacteria and Archaea (Grønlund and Gerdes 1999; Makarova et al. 2009; Pandey and Gerdes 2005; Gerdes et al. 2005; Krupovic et al. 2013) . The chromosomes of some of these bacteria contain several TA loci, especially in one of the Mycobacterium species, M. tuberculosis, which possesses the largest number of putative TA loci on its chromosome, accounting for 79 loci (Ramage et al. 2009 ). TA systems consist of two small genes that Abstract There are 12 putative toxin-antitoxin (TA) loci in the Thermus thermophilus HB27 genome, including four VapBC and three HicBA families. Expression of these seven putative toxin genes in Escherichia coli demonstrated that one putative VapC toxin TTC0125 and two putative HicA toxins, TTC1395 and TTC1705, inhibited cell growth, and co-expression with cognate antitoxin genes rescued growth, indicating that these genes function as TA loci. In vitro analysis with the purified TTC0125 and total RNA/mRNA from E. coli and T. thermophilus showed that TTC0125 has RNase activity to rRNA and mRNA; this activity was inhibited by the addition of the purified TTC0126. Translation inhibition assays showed that TTC0125 inhibited protein synthesis by degrading mRNA but not by inactivating ribosomes. Amino acid substitutions of 14 predicted catalytic and conserved residues in VapC toxins to Ala or Asp in TTC0125 indicated that nine residues are important for its in vivo toxin activity and in vitro RNase activity. These data demonstrate that TTC0125-TTC0126 functions as a VapBC TA module and causes growth inhibition by degrading free RNA. This is the first study to identify the function of TA systems in T. thermophilus.
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encode a low molecular weight toxic protein (toxin) which reacts with intracellular target molecules related to essential cellular processes, such as DNA replication, protein translation, membrane integrity, and cell wall synthesis (Bertram and Schuster 2014; Maisonneuve et al. 2013; Page and Peti 2016) , and a cognate antitoxin protein or RNA that inhibits toxin activity. Initially, TA loci were reported to play a role in bacterial programmed cell death for maintaining plasmid stability by killing the daughter cells that failed to inherit the plasmids (Winther and Gerdes 2011) , or for acting as antiviral factors (Hazan and Engelberg-Kulka 2004; Pecota and Wood 1996) . More recently, it was recognized that the toxins play roles in response to cellular stresses (Bertram and Schuster 2014) , such as amino acid starvation and the presence of antibiotics (Fauvart et al. 2011; Gerdes et al. 2005; Maisonneuve and Gerdes 2014) , and triggering bacterial persistence (Yamaguchi and Inouye 2011) . The vast majority of TA systems in chromosomes of Bacteria and Archaea are not redundant, likely due to each system developing different responses to specific stresses (Wang and Wood 2011) . Currently, TA systems are grouped into six classes according to the mechanisms used by the antitoxins to neutralize the activities of the toxins.
The type II TA system is composed of a stable toxin protein and an unstable antitoxin protein. Under normal growth conditions, the antitoxin neutralizes toxin activity by forming a stable protein complex. When an environmental stressor is present, the antitoxin protein is degraded via proteolysis such that the toxin is released from the protein complex and becomes active to target intracellular molecules, such as mRNA at the ribosomal A site (Christensen and Gerdes 2003), initiator tRNA fMet (Winther and Gerdes 2011) , Sarcin-Ricin loop of 23S rRNA (Winther et al. 2013) , and glutamyl-tRNA synthetase (Germain et al. 2013) , to inhibit cell growth or cause cell death. Most type II toxins function as RNases for degrading mRNA, either in a ribosome-dependent or independent manner (Unterholzner et al. 2014) , such as MazF, Kid, ChpBK, MqsR, VapC, and HicA.
VapBC of the type II TA system is the most widely expanded TA family and its toxin, VapC, contains a PIN domain, which functions as a nuclease enzyme and cleaves single stranded RNA (Arcus et al. 2011) . VapBC is often found in prokaryotic organisms, such as M. tuberculosis, one of the most devastating pathogenic bacteria, which contains 45 VapBC loci (Arcus et al. 2011) ; however, most have not been well characterized until recently. The PIN domain consists of three highly conserved negatively charged amino acids and is predicted to have RNase activity (Arcus et al. 2011) . VapC toxins from different organisms were reported to have different target specificities; for example, VapC20 of M. tuberculosis inhibits translation by cleavage of 23S ribosomal RNA (Winther et al. 2013) , and both VapC of Shigella flexneri and VapCLT2 of Salmonella enterica site specifically cleave initiator tRNA (Winther and Gerdes 2011); on the other hand, VapC-mt4 of M. tuberculosis degrades mRNA (Sharp et al. 2012) .
Little is known about HicAB, a novel Type II TA system family that was identified by Makarova et al. (2006) . The Escherichia coli HicA toxin inhibits cell growth by mRNA degradation (Jørgensen et al. 2009) , and the HicA from Burkholderia pseudomallei and Pseudomonas aeruginosa induces growth arrest and persistence in the presence of ciprofloxacin or ceftazidime (Butt et al. 2014; Li et al. 2016) .
Despite many studies on mesophilic bacteria, including pathogens, the mechanisms and roles of TA systems in thermophilic microorganisms remain unknown. Based on the toxin-antitoxin database (Shao et al. 2011) , 12 TA loci are predicted to be present in the T. thermophilus HB27 genome, of which seven are classified into known TA families, three (TTC1395-TTC1394, TTC1549-TTC1548, and TTC1705-TTC1704) in HicAB and four (TTC0113-TTC0114, TTC0125-TTC0126, TTC1207-TTC1208, and TTC1804-TTC1805) in VapBC; however, experimental analyses on these TA loci have not yet been reported. Here, we document the results of genetic analyses of these seven loci, and present detailed biochemical analyses of TTC0125-TTC0126.
Materials and methods
Bacterial strains, plasmids and media T. thermophilus HB27 was used for genome isolation and purification of total RNA. E. coli strains DH5αZ1 (DH5α harboring attB::P lacI q -lacI, P N25 -tetR, Sp r ; Lutz and Bujard 1997) and Rosetta (DE3) were used for plasmid construction and expression of toxin/TA genes from pZE21MCS (ColE1ori, P LtetO-1 , Kn r ; Lutz and Bujard 1997) and for production of TTC0125/TTC0126 proteins with pET28a, respectively. DH5αZ1 and pZE21MCS were purchased from Expressys. T. thermophilus and E. coli strains were cultured in TM medium (Koyama et al. 1986 ) at 70 °C and in LB medium at 37 °C, respectively.
Plasmid construction
To construct plasmids expressing the toxin genes or the TA modules under the control of a strictly regulated promoter, P LtetO-1 , each toxin gene or the TA locus was PCR amplified with the primers listed in Table S1 from the T. thermophilus HB27 genome. Then, fragments were digested with KpnI and SalI, which were added just upstream of the initiation codon and downstream of the termination codon, respectively, and cloned into the respective sites of pZE21MCS, using strain DH5αZ1 as a host.
For production and purification of the TTC0125 toxin and TTC0126 antitoxin, the TA locus and TTC0126 were PCR amplified with primers TTC0126 F NdeI and TTC0125 R XhoI, and TTC0126 F NdeI and TTC0126 R XhoI, respectively. The resultant fragments were cloned into the respective sites of pET28a, giving rise to pET28-TTC0125-TTC0126 and pET28-TTC0126, respectively. In both plasmids, TTC0126 was fused in-frame with the 6xHis-tag in the vector at the N terminus, and the XhoI site was located just downstream of the termination codon of TTC0125 of pET28-TTC0125-TTC0126 and TTC0126 of pET28-TTC0126.
The TT_P0042 gene encoding a β-glycosidase was PCR amplified and cloned into pET28a, giving rise to pET28-TTP0042. This plasmid was used for in vitro transcription and translation assays. The tetR gene from E. coli was also cloned into pET28a to construct pET28-tetR, and used for in vitro transcription and RNase assays.
All plasmid constructs were confirmed by nucleotide sequencing with a CEQ8000XL DNA sequencer (Beckman-Coulter).
Growth inhibition assay
The strain DH5αZ1 harboring the pZE21MCS plasmid containing each toxin gene or TA locus was cultured in liquid LB medium with 50 μg/mL of kanamycin at 43 °C. When the O.D. 600 of the culture reached approximately 0.2, 100 ng/mL doxycycline (Dox) was added to induce gene expression. Cell growth was monitored periodically by measuring O.D. 600 . Three independent experiments were performed.
Purification of TTC0125 and TTC0126
The TTC0125 toxin was purified according to Winther and Gerdes (2011) . E. coli Rosetta (DE3) harboring pET28-TTC0125-TTC0126 was cultured in LB medium supplemented with 50 μg/mL kanamycin and 20 μg/mL chloramphenicol at 30 °C. When O.D. 600 reached 0.5, 0.2 mM IPTG was added, and, after further culturing for 5 h, cells were collected by centrifugation at 5000×g for 10 min at 4 °C. Then, the cells were re-suspended in ice-cold Lysis buffer (50 mM NaH 2 PO 4 , 100 mM NaCl, 20 mM imidazole, 0.5 mM PMSF (SIGMA), pH 7.4), and disrupted by sonication. After the cell debris were removed by centrifugation at 10,000×g for 20 min at 4 °C, a Ni-NTA agarose resin (Qiagen) was added to the supernatant and incubated for 2 h at 4 °C, and subsequently loaded onto a gravity column. The column was washed extensively with Wash buffer (50 mM NaH 2 PO 4 , 100 mM NaCl, 20 mM imidazole, pH 7.4), and the protein complex of TTC0125-TTC0126 was eluted with Elution buffer (50 mM NaH 2 PO 4 , 100 mM NaCl, 200 mM imidazole, pH 7.4). Next, the protein complex was denatured by dialyzing the complex overnight at 4 °C with Denaturation buffer (100 mM NaH 2 PO 4 , 10 mM Tris-HCl, 9.8 M Urea, pH 7.4), and the solution was again loaded onto a Ni-NTA agarose column. The denatured TTC0125 was eluted in the flow-through fraction, and refolded by the subsequent four-step dialysis against: (1) 1 × PBS, 0.1% Triton X-100, 5 mM DTT, (2) 1 × PBS, 5 mM DTT, (3) 1×PBS, 5 mM DTT, and (4) 1 × PBS, 20% glycerol, 1 mM DTT for 4 h in each dialysis.
For purification of TTC0126, E. coli Rosetta (DE3) harboring pET28-TTC0126 was cultured and the cell-free extract was prepared as previously described. TTC0126 was purified from the extract directly with a Ni-NTA agarose. The purification steps were monitored by SDS-PAGE according to Laemmli (1970) .
RNA degradation assay
100 pmol of the purified TTC0125 protein, dialyzed against Reaction buffer (50 mM Tris-HCl, 100 mM NaCl, 10 mM MgCl 2 , 1 mM DTT, pH 7.4) prior to the reaction, was incubated with 1 μg of total RNA from E. coli and T. thermophilus, which was prepared using an RNeasy Mini Kit (Qiagen), or an in vitro-transcribed tetR mRNA, which was prepared using pET28-tetR and an in vitro Transcription T7 Kit (TAKARA) and purified with RNeasy Mini Kit (Qiagen) kit, at 50 °C in Reaction buffer. After 5, 15, 30, or 60 min of incubation, the reaction was stopped by adding 1× loading buffer (47.5% formamide, 0.01% SDS, 0.01% bromophenol blue, 0.5 mg/mL EtBr, 0.5 mM EDTA) and placed on ice immediately. Then, the samples were loaded onto a denaturing agarose gel (1% agarose, 6.5% formaldehyde, 0.4 M MOPS, 100 mM sodium acetate, 10 mM EDTA) and analyzed. To test the inhibitory effect of TTC0126, 100 pmol of TTC0125 was incubated with 500 pmol of the purified TTC0126, which was also dialyzed against Reaction buffer, at 50 °C for 15 min prior to the reaction, and used for the assay.
For measuring activity against intact ribosomes, ribosomes were purified from E. coli and T. thermophilus cells according to Pongs et al. (1973) and Trauner et al. (2011) . Then, 10 μg of TTC0125 was incubated with 50 μg of ribosomes in Reaction buffer at 50 °C for 60 min, and rRNA was purified with an RNeasy Mini Kit for gel electrophoresis.
For measuring activity against tRNA, the small RNA fraction containing tRNA was prepared from E. coli using ISOGEN II (NIPPON GENE). Then, 1 μg of the sample was incubated with TTC0125 as previously described, and resolved by an 8% denaturing PAGE. After the sample was electroblotted onto a Hybond-N membrane, the initiator tRNA was hybridized with a biotin-labeled DNA probe, tRNAMet. Detection was conducted using a Chemiluminescent Nucleic Acid Detection Module (Thermo Fisher Scientific) and an LAS-2000 detector (Fuji film).
In vitro translation inhibition assay
An in vitro translation inhibition assay was performed under the following conditions, using the in vitro-transcribed TT_P0042 mRNA, which was synthesized with pET28-TTP0042 as a template and the in vitro Transcription T7 Kit, and a PUREfrex 2.0 kit (GeneFrontier; Shimizu et al. 2001) . For each condition, the amount of the purified TTC0125, TTC0126 proteins, and the template mRNA used were 45, 270 pmol, and 2.5 µg, and the substrate-tRNA mixture (solution I, PUREfrex), the enzyme mixture (solution II), and the ribosome (solution III) solutions used were 10, 1, and 2 µL in a total volume of 20 µL, respectively.
Condition 1 The template mRNA was incubated with TTC0125 at 37 °C for 30 min prior to in vitro translation.
Condition 2 The template mRNA was incubated with TTC0125 as previously described, then TTC0126 was added and the solution was further incubated for 15 min. After that, the translation reaction was started.
Condition 3 TTC0125 and TTC0126 were mixed and incubated at 37 °C for 15 min. Then the template mRNA was added and incubated further for 30 min. After that, the translation reaction was started.
Condition 4 The ribosome (solution III) was incubated with TTC0125 at 37 °C for 30 min, then, the translation reaction was started by adding the template mRNA, solutions I and II.
Condition 5 The ribosome was incubated with TTC0125 as previously described, then TTC0126 was added and the solution was further incubated for 15 min. After that, the translation reaction was started.
Condition 6 TTC0125 and TTC0126 were mixed and incubated at 37 °C for 15 min, then the ribosome was added and incubated further for 30 min. After that, the translation reaction was started.
The in vitro translation reaction was performed at 37 °C for 4 h, and the translated TT_P0042 protein, containing the 6×His-tag at its N terminus, was detected by Western blotting using an anti-His antibody (Qiagen) and an ECL Prime Western Blotting Detection kit (GE Healthcare). Detection was performed using an LAS-2000 detector (Fuji film).
Site-directed mutagenesis
Single amino acid-substitution mutants of TTC0125 were constructed using the pZE21MCS plasmid harboring TTC0125 and pET28-TTC0125-TTC0126 as templates, primers listed in Table S1 , and a QuickChange site-directed mutagenesis kit (Agilent Technologies). The resultant pZE21MCS plasmids harboring the mutant TTC0125 were used for the growth inhibition assays, and pET28-TTC0125-TTC0126 harboring mutant genes were used for protein purification and biochemical assays, as previously described.
Results and discussion

Identification of functional TA loci through growth inhibition assays
In the T. thermophilus HB27 genome, seven TA loci were predicted to be known TA families in the toxin-antitoxin database (Shao et al. 2011) . Similarity searches of these putative toxins with the validated toxins in the Uniprot database indicated low-to-moderate similarities. TTC0113, TTC0125, TTC1207, and TTC1804, classified in the VapC family, showed 24, 44, 12, and 13% similarity to VapC of Mycobacterium smegmatis (VAPC_MYCS2) (McKenzie et al. 2012) , and TTC1395, TTC1549 and TTC1705 showed 37, 13 and 42% similarity to HicA of E. coli (HICA_ECOLI), respectively (Jørgensen et al. 2009 ). Likewise, their cognate antitoxins also showed similar results. TTC0114, TTC0126, TTC1208, and TTC1805 showed 24, 37, 18, and 47% similarity to the VapB antitoxin of M. smegmatis (VAPB_MYCS2), and TTC1394, TTC1548, and TTC1704 showed 27, 35 and 27% similarity to the HicB antitoxin of E. coli (HICB_ECOLI), respectively.
To test whether these seven TA loci are functional, the toxin genes were cloned with or without their cognate antitoxin genes into the plasmid pZE21MCS and expressed under the control of the P LtetO-1 promoter in E. coli. This promoter is strictly regulated in the presence of the TetR repressor in strain DH5αZ1, and expression can be induced with the addition of Dox (Lutz and Bujard 1997) . Strains harboring the plasmids were cultured at 43 °C and gene expression was induced when the O.D. 600 of the culture reached approximately 0.2.
As shown in Fig. 1a , expression of one VapC (TTC0125) and two HicA (TTC1395, TTC1549) genes strictly inhibited cell growth, whereas the other toxin genes had almost no effect. The growth-inhibitory effects of the former three toxin genes were more evident at 43 °C compared to 37 °C (data not shown), indicating that these toxins are more active at higher temperatures. Moreover, the effects were canceled out by co-expression of their cognate antitoxin genes (Fig. 1b) .
The method used is restricted by assay temperature, as an E. coli strain is used as the host. Therefore, we cannot exclude the possibility that the other four toxins may also possess toxin activities at higher temperatures, i.e., the growth temperature of T. thermophilus. However, we concluded that at least these three loci function as type II TA systems in T. thermophilus, and focused on the TTC0125/TTC016 locus for further analysis. As these genes are classified into the VapBC family, we hereinafter renamed TTC0125 and TTC0126 as TtVapC and TtVapB, respectively.
Purification of TtVapC and TtVapB
We adopted the method described by Winther and Gerdes (2011) for TtVapC purification. The TtVapBC protein complex was first purified from the cell extracts of E. coli Rosetta (DE3) harboring pET28-TTC0125-TTC0126 through affinity chromatography against the 6xHis-tag attached to the N-terminus of TtVapB; the proteins were denatured with a 9.8 M urea treatment. Then, the sample was loaded to the Ni-NTA agarose column and TtVapC was purified in a flow-through fraction. The purified TtVapC was renatured by a step-wise dialysis, and TtVapB was directly purified by the affinity chromatography from the cell extract of strain Rosetta (DE3) harboring pET28-TTC0126.
The purified TtVapC and TtVapB showed single bands on SDS-PAGE, the size of which were 14.7 and 10.0 kDa, respectively (Fig. 2) .
TtVapC degrades free RNA but not tRNA or rRNA in intact ribosomes
VapC family proteins contain a PIN domain and function as RNases (Arcus et al. 2011) . To assess the molecular Fig. 1 Growth inhibition assay. E. coli DH5αZ1 harboring pZE21MCS containing toxin genes (a) of TTC0113 (1), TTC0125 (2), TTC1207 (3), TTC1804 (4), TTC1395 (5), TTC1549 (6), TTC1705 (7) function of TtVapC, we first analyzed its RNase activity using total RNA isolated from both E. coli and T. thermophilus as substrates. As shown in Fig. 3a, b , the major bands corresponding to 16S and 23S rRNA were gradually shifted to low molecular weight fractions across incubation time with TtVapC, indicating that TtVapC degrades at least 16S and 23S rRNA from both organisms. This degradation was completely inhibited when TtVapC was incubated with TtVapB prior to the reaction, showing that TtVapB functions as antitoxin.
Some VapC toxins show strict substrate specificities towards rRNA and tRNA. For example, VapC20 of M. tuberculosis cleaves the Sarcin-Ricin loop of 23S rRNA in the intact ribosome (Winther et al. 2013) , and VapC (MvpT) of Shigella flexneri cleaves the anticodon loop of the initiator tRNA (Winther and Gerdes 2011) . To examine whether TtVapC has such substrate specificities, we first evaluated its activity toward intact ribosomes from E. coli and T. thermophilus. As shown in Fig. S1a, b , TtVapC did not cleave or degrade 16S or 23S rRNA from both organisms. To assess initiator tRNA cleavage, small RNA fraction from E. coli was used as a substrate and the tRNA was detected by Northern blot hybridization. TtVapC also did not react with the initiator tRNA (Fig. S1c) . However, TtVapC degrades in vitro-transcribed mRNA of the E. coli gene (tetR) in the same manner as total RNA (Fig. 3c) . These results strongly indicate that TtVapC does not possess substrate or sequence specificity, rather it degrades free RNA, such as VapC6 of Sulfolobus solfataricus (Maezato et al. 2011) , and those or TtVapC D99A mutant (lane 6) for 60 min and electrophoresed by denaturing agarose gel. Lanes C indicate the RNA samples without TtVapC treatment, which were also incubated in reaction buffer for 60 min. Positions of 23S, 16S rRNA, and mRNA are indicated by arrows Fig. 4 In vitro translation inhibition assay. The in vitro-transcribed TT_P0042 mRNA or the E. coli ribosome fraction in the PUREfrex 2.0 kit were incubated with the TtVapC or TtVapBC complex, as described in "Materials and methods", and in vitro translation reactions were conducted by adding other components of the kit. The translated product was resolved by SDS-PAGE and detected by Western blotting with an anti-His antibody. Lane 1 the mRNA was pre-incubated with TtVapC (Condition 1); 2 the mRNA was pre-incubated with TtVapC, and then TtVapB was added (Condition 2); 3 the mRNA was pre-incubated with TtVapBC complex (Condition 3); 4 the mRNA was pre-incubated with TtVapC D99A mutant in Condition 1; 5 the ribosome was pre-incubated with TtVapC (Condition 4); 6 the ribosome was pre-incubated with TtVapC, and then TtVapB was added (Condition 5); 7 the ribosome was pre-incubated with TtVapBC complex (Condition 6); 8 the ribosome was pre-incubated with TtVapC D99A mutant in Condition 4. Lanes NC and PC indicate negative control without the template mRNA addition and positive control without TtVapC treatment, respectively. Lane M indicates the molecular marker standards (MagicMark XP Western Protein Standard, Thermo Fisher Scientific), the size of which are indicated on the right. The bands corresponding to the full-length-translated product are indicated by an arrow of some pathogenic bacteria (Daines et al. 2007; Ramage et al. 2009 ).
TtVapC inhibits translation by degrading mRNA
To gain insights into the in vivo molecular function of TtVapC, an in vitro translation assay was conducted using a PUREfrex kit. In this assay, an in vitro-transcribed TT_ P0042 mRNA was used as a template for translation and translated 6xHis-tagged protein was detected by Western blotting.
A control experiment (without TtVapC addition) produced a band of ca. 50.8 kDa corresponding to the molecular weight of the TT_P0042 protein with a 6× His-tag (Fig. 4) . When the mRNA was incubated with TtVapC prior to translation, no band was observed; also, the band was not observed when TtVapB was added after incubation of the mRNA with TtVapC. As the TT_P0042 protein was successfully translated when the mRNA was incubated with the TtVapBC complex, it seems likely that TtVapC inhibits translation by degrading mRNA. However, pretreatment of ribosomes with TtVapC resulted in a reduction of the translated product; this reduction did not occur when TtVapB was added to the ribosome-TtVapC mixture before the translation reaction. Therefore, this result was likely caused by active TtVapC degradation of mRNA during translation reaction but not inactivation of ribosomes. Pre-incubation of ribosome with TtVapBC did not affect translation efficiency. We, therefore, conclude that TtVapC inhibits translation by degrading mRNA and thereby inhibiting cell growth.
Identification of functionally important residues in TtVapC
We conducted site-directed mutagenesis to identify catalytically important residues of TtVapC. An amino acid sequence alignment of TtVapC with "reviewed" VapCs in the Uniprot database (Fig. S2 ) generated by the T-Coffee program (Notredame et al. 2000) indicated that some residues, including the putative catalytic residues in PIN proteins, D4, E40, and D99 in TtVapC numbering, are conserved in all VapCs. In addition, some residues are conserved in several but not in all VapCs. We selected those residues, including the putative catalytic residues, and introduced single amino acid substitutions to Ala or Asp. The mutant genes were then introduced into E. coli DH5αZ1 on pZE21MCS and the growth inhibition assays were conducted.
As shown in Fig. S3 , the E23A, T72A, L105D, and V108D mutants showed similar growth inhibition as the wild-type TtVapC gene, suggesting that these residues are not required for its toxin activity. The F71A mutant showed a weaker growth inhibition, suggesting that this residue may be required for this activity to some extent. In contrast, the D4A, E40A, A76D, G94D, G98D, D99A, S102D, D119A, and D124A mutants, including the mutants of the putative catalytic residues, had almost no effect on cell growth, demonstrating the importance of these residues for its in vivo toxin activity.
Since the three-dimensional structure of TtVapC is currently unavailable, we developed a three-dimensional model using the Phyre2 program to gain insight into the structure-activity relationship of TtVapC (Kelly et al. 2015) . The Phyre2 program indicated that TtVapC showed a 37% identity with VapC30 of M. tuberculosis H37Rv (PDB No. 4xgr), and a model structure of the second to 128th amino acid of TtVapC was constructed based on that of VapC30 with a 100% confidence, indicating the accuracy of the model.
Mapping of the mutated residues on the model structure ( Fig. 5a ) indicated that the three putative catalytic residues, whose mutations led to complete loss of growth inhibition activity, are located in one place with nearly the same topologies and distances of the side chains with those of VapC30, possibly forming the catalytic center. The other residues whose mutations also resulted in complete or partial loss of activity, except for G94 and D124, are located around the putative catalytic center, suggesting that these residues are involved in substrate binding or structural maintenance of the putative catalytic center. In the case of G98, since the Gly residue acts as a helix breaker and this residue is located adjacent to one of the catalytic residues, D99, G98 may be required for correct positioning of D99; it remains unknown as to why the mutations of G94D and D124A lost growth inhibition activity. The E23, T72, L105, and V108 residues are located at the other side of the protein. Therefore, it is possible that mutations of these residues did not affect activity.
To examine the mutant proteins which lost growth inhibition activity biochemically, the proteins were purified using the same method as the wild-type TtVapC. As shown in Fig. 5b , all of the mutant proteins were purified as single bands. Since this purification method relies on the complex formation with TtVapB, this result indicates that the mutations introduced did not affect binding to TtVapB. As expected, all mutants lost RNase activities against total RNA (Fig. 5c) , and one of the mutants, D99A, also lost activity against mRNA (Fig. 3c ) and translation inhibition activity (Fig. 4) .
In conclusion, we characterized seven putative TA loci in T. thermophilus, and found that the three loci, TTC0125-TTC0126, TTC1395-TTC1396, and TTC1705-TTC1706, function as a TA module, indicated by the E. coli growth inhibition assay. Biochemical analysis indicated that TtVapC catalyzes degradation of RNA and inhibits translation by degrading free mRNA, and TtVapB inhibits its activity as the antitoxin. Nine catalytically important residues in TtVapC, including the three putative catalytic residues, were identified, most of which are located near the catalytic center of the three-dimensional model.
Most vapBC loci in microorganisms consist of a bicistronic operon but the TtvapBC locus is included in a gene cluster encoding metabolic enzymes related to the glyoxylate cycle. It is possible that the physiological function of TtVapBC is related to this cycle. Residues to which the mutations were introduced are shown with side chains and introduced mutations are indicated. Residues whose mutations affected growth inhibition activity are shown in orange and magenta, of which orange residues indicate the putative catalytic residues. Those whose mutations did not affect the activity are shown in blue. Purification (b) and RNA degradation assay (c) of the purified TtVapC mutants. Lane 1 wild-type TtVapC, 2 D4A, 3 E40A, 4 A76D, 5 G94D, 6 G98D, 7 D99A, 8 S102D, 9 D119A, 10 D124A mutants. Lanes M and C indicate molecular markers (in kDa) and a control experiment without TtVapC incubation, respectively. RNA degradation assays were conducted with E. coli total RNA, and the positions of 23S and 16S rRNA are indicated by arrows
